A) B) C) D - PLOS

Download PDF
12 downloads 0 Views 89KB Size Report
Comment
Days elapsed. Pe rc e n. t s u rv iv a l. Control. Treated. M3. D3. OS (% d eath any Cau se). Days. C). SF3B1/EIF1AX. BAP1. D). SF3B1/EIF1AX. BAP1.
Supplemental Fig. 2

B)

C o n tro l

100

T re a te d

D3 50

M3 0 0

1000

2000

3000

S u r v iv a l p r o p o r t io n s : S u r v i v a l o f M 3 v s D 3 O S a n y

OSP(% e r cdeath e n t s uany r v iv aCause) l

S u r v iv a l p r o p o r t io n s : S u r v iv a l o f M 3 v s D 3 O S d e f M U M c e n t s ufrom r v iv a MUM) l OS P(%e rdeath

A)

C o n tro l

100

T re a te d

D3 50

M3 0

4000

0

D a y s e la p s e d

1000

2000

3000

4000

D a y s e la p s e d

Days

Days

D)

C) SF3B1/EIF1AX

BAP1

SF3B1/EIF1AX

BAP1